Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross J Porter

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Age and Ageing|May 26, 2021
Lessons from recent medical history: an obsolete anti-reflux device in an older patient with variable gastrointestinal symptomsCharlotte Squires, Ross J Porter, Benjamin M Ward
F1000Research|May 14, 2020
Ulcerative colitis: Recent advances in the understanding of disease pathogenesisRoss J Porter, Rahul Kalla, Gwo-Tzer Ho
British Journal of Cancer|July 31, 2020
Current concepts in tumour-derived organoidsRoss J Porter, Graeme I Murray, Mairi H McLean
Frontline Gastroenterology|June 20, 2022
Endoscopically placed venting gastrostomy can be a safe and effective palliative intervention in benign and malignant gastrointestinal obstructionRoss J Porter, Alastair W McKinlay, Emma L Metcalfe
Frontline Gastroenterology|September 5, 2020
Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up auditRoss J Porter, Alastair W McKinlay, Emma L Metcalfe
Diagnostics (Basel, Switzerland)|June 10, 2023
QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue MicroarrayRoss J Porter, Shahida Din, Peter Bankhead, et al.
Journal of Crohn'S & Colitis|June 10, 2021
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to MedicinesRoss J Porter, Mark J Arends, Antonia M D Churchhouse, et al.
World Journal of Gastroenterology|June 1, 2022
c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesionsGrant Halliday, Ross J Porter, Catherine J Black, et al.
British Journal of Cancer|December 14, 2019
Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotypeRoss J Porter, Graeme I Murray, Daniel P Brice, et al.
Biology|March 26, 2022
Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid ModelDaniel P Brice, Graeme I Murray, Heather M Wilson, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Age and Ageing|May 26, 2021
Lessons from recent medical history: an obsolete anti-reflux device in an older patient with variable gastrointestinal symptomsCharlotte Squires, Ross J Porter, Benjamin M Ward
F1000Research|May 14, 2020
Ulcerative colitis: Recent advances in the understanding of disease pathogenesisRoss J Porter, Rahul Kalla, Gwo-Tzer Ho
British Journal of Cancer|July 31, 2020
Current concepts in tumour-derived organoidsRoss J Porter, Graeme I Murray, Mairi H McLean
Frontline Gastroenterology|June 20, 2022
Endoscopically placed venting gastrostomy can be a safe and effective palliative intervention in benign and malignant gastrointestinal obstructionRoss J Porter, Alastair W McKinlay, Emma L Metcalfe
Frontline Gastroenterology|September 5, 2020
Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up auditRoss J Porter, Alastair W McKinlay, Emma L Metcalfe
Diagnostics (Basel, Switzerland)|June 10, 2023
QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue MicroarrayRoss J Porter, Shahida Din, Peter Bankhead, et al.
Journal of Crohn'S & Colitis|June 10, 2021
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to MedicinesRoss J Porter, Mark J Arends, Antonia M D Churchhouse, et al.
World Journal of Gastroenterology|June 1, 2022
c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesionsGrant Halliday, Ross J Porter, Catherine J Black, et al.
British Journal of Cancer|December 14, 2019
Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotypeRoss J Porter, Graeme I Murray, Daniel P Brice, et al.
Biology|March 26, 2022
Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid ModelDaniel P Brice, Graeme I Murray, Heather M Wilson, et al.
Pageof 2